Nuvation Bio Inc.
NUVB
$2.11
-$0.08-3.65%
NYSE
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -46.00% | 685.56% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -46.00% | 685.56% | |||
| Cost of Revenue | -50.33% | 178.28% | |||
| Gross Profit | -33.78% | 289.72% | |||
| SG&A Expenses | 35.41% | 33.48% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.08% | 22.17% | |||
| Operating Income | -9.38% | -12.14% | |||
| Income Before Tax | -7.67% | -19.98% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -7.67% | -19.98% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -7.67% | -19.98% | |||
| EBIT | -9.38% | -12.14% | |||
| EBITDA | -9.25% | -12.07% | |||
| EPS Basic | -7.16% | 2.59% | |||
| Normalized Basic EPS | -7.20% | 2.55% | |||
| EPS Diluted | -9.07% | 2.59% | |||
| Normalized Diluted EPS | -7.20% | 2.55% | |||
| Average Basic Shares Outstanding | 0.50% | 23.16% | |||
| Average Diluted Shares Outstanding | 0.50% | 23.16% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||